메뉴 건너뛰기




Volumn 2, Issue 1, 2007, Pages 31-36

Weight Gain and Management Concerns in Patients on Insulin Therapy

Author keywords

cardiovascular disease; insulin; type 2 diabetes mellitus; weight gain

Indexed keywords

CHLORPROPAMIDE; EXENDIN 4; GLIBENCLAMIDE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LIPID; LONG ACTING DRUG; METFORMIN; ORAL ANTIDIABETIC AGENT; PRAMLINTIDE; SHORT ACTING DRUG; SIBUTRAMINE; SULFONYLUREA; TETRAHYDROLIPSTATIN;

EID: 34548236887     PISSN: 15570843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1557-0843(07)80031-5     Document Type: Article
Times cited : (7)

References (45)
  • 1
    • 0032511583 scopus 로고    scopus 로고
    • Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 2
    • 33645861392 scopus 로고    scopus 로고
    • Summary of revisions for the 2006 Clinical Practice Recommendations
    • Members of the Professional Practice Committee
    • Members of the Professional Practice Committee. Summary of revisions for the 2006 Clinical Practice Recommendations. Diabetes Care 29 Suppl 1 (2006) S3
    • (2006) Diabetes Care , vol.29 , Issue.SUPPL. 1
  • 3
    • 0031972156 scopus 로고    scopus 로고
    • UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
    • for the UK Prospective Diabetes Study (UKPDS) Group
    • Matthews D., Cull C., Stratton I., et al., for the UK Prospective Diabetes Study (UKPDS) Group. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabet Med 15 (1998) 297-303
    • (1998) Diabet Med , vol.15 , pp. 297-303
    • Matthews, D.1    Cull, C.2    Stratton, I.3
  • 4
    • 0037167920 scopus 로고    scopus 로고
    • Clinical practice
    • Initial management of glycemia in type 2 diabetes mellitus
    • Nathan D. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 347 (2002) 1342-1349
    • (2002) N Engl J Med , vol.347 , pp. 1342-1349
    • Nathan, D.1
  • 5
    • 0023777821 scopus 로고
    • Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes
    • Glaser B., Leibovich G., Nesher R., et al. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol (Copenh) 118 (1988) 365-373
    • (1988) Acta Endocrinol (Copenh) , vol.118 , pp. 365-373
    • Glaser, B.1    Leibovich, G.2    Nesher, R.3
  • 6
    • 0036274789 scopus 로고    scopus 로고
    • A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment
    • Karvestedt L., Andersson G., Efendic S., and Grill V. A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment. J Intern Med 251 (2002) 307-316
    • (2002) J Intern Med , vol.251 , pp. 307-316
    • Karvestedt, L.1    Andersson, G.2    Efendic, S.3    Grill, V.4
  • 7
    • 0030751382 scopus 로고    scopus 로고
    • Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
    • Ilkova H., Glaser B., Tunckale A., et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20 (1997) 1353-1356
    • (1997) Diabetes Care , vol.20 , pp. 1353-1356
    • Ilkova, H.1    Glaser, B.2    Tunckale, A.3
  • 8
    • 2342587418 scopus 로고    scopus 로고
    • Short-term intensive insulin therapy in newly diagnosed type 2 diabetes
    • Ryan E., Imes S., and Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 27 (2004) 1028-1032
    • (2004) Diabetes Care , vol.27 , pp. 1028-1032
    • Ryan, E.1    Imes, S.2    Wallace, C.3
  • 9
    • 7444234167 scopus 로고    scopus 로고
    • Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function
    • Li Y., Xu W., Liao Z., et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 27 (2004) 2597-2602
    • (2004) Diabetes Care , vol.27 , pp. 2597-2602
    • Li, Y.1    Xu, W.2    Liao, Z.3
  • 10
    • 0029149751 scopus 로고
    • Effects of early introduction of intensive insulin therapy on the clinical course in nonobese NIDDM patients
    • Kayashima T., Yamaguchi K., Konno Y., et al. Effects of early introduction of intensive insulin therapy on the clinical course in nonobese NIDDM patients. Diabet Res Clin Pract 28 (1995) 119-125
    • (1995) Diabet Res Clin Pract , vol.28 , pp. 119-125
    • Kayashima, T.1    Yamaguchi, K.2    Konno, Y.3
  • 11
    • 0041523870 scopus 로고    scopus 로고
    • Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients
    • Alvarsson M., Sundkvist G., Lager I., et al. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care 26 (2003) 2231-2237
    • (2003) Diabetes Care , vol.26 , pp. 2231-2237
    • Alvarsson, M.1    Sundkvist, G.2    Lager, I.3
  • 12
    • 0027389342 scopus 로고
    • Intensive conventional insulin therapy for type II diabetes
    • Metabolic effects during a 6-mo outpatient trial
    • Henry R., Gumbiner B., Ditzler T., et al. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care 16 (1993) 21-31
    • (1993) Diabetes Care , vol.16 , pp. 21-31
    • Henry, R.1    Gumbiner, B.2    Ditzler, T.3
  • 13
    • 0344609217 scopus 로고    scopus 로고
    • Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus
    • Makimattila S., Nikkila K., and Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 42 (1999) 406-412
    • (1999) Diabetologia , vol.42 , pp. 406-412
    • Makimattila, S.1    Nikkila, K.2    Yki-Jarvinen, H.3
  • 14
    • 0028289461 scopus 로고
    • Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure
    • Lindstrom T., Eriksson P., Olsson A., and Arnqvist H. Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care 17 (1994) 719-721
    • (1994) Diabetes Care , vol.17 , pp. 719-721
    • Lindstrom, T.1    Eriksson, P.2    Olsson, A.3    Arnqvist, H.4
  • 15
    • 9844269567 scopus 로고    scopus 로고
    • Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus
    • Yki-Jarvinen H., Ryysy L., Kauppila M., et al. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82 (1997) 4037-4043
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 4037-4043
    • Yki-Jarvinen, H.1    Ryysy, L.2    Kauppila, M.3
  • 17
    • 0034819464 scopus 로고    scopus 로고
    • Combination therapies with insulin in type 2 diabetes
    • Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 24 (2001) 758-767
    • (2001) Diabetes Care , vol.24 , pp. 758-767
    • Yki-Jarvinen, H.1
  • 18
    • 0035486744 scopus 로고    scopus 로고
    • Insulin therapy does not itself induce weight gain in patients with type 2 diabetes
    • Larger E., Rufat P., DuBois-Laforgue D., and Ledoux S. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes. Diabetes Care 24 (2001) 1849-1850
    • (2001) Diabetes Care , vol.24 , pp. 1849-1850
    • Larger, E.1    Rufat, P.2    DuBois-Laforgue, D.3    Ledoux, S.4
  • 19
    • 0033928159 scopus 로고    scopus 로고
    • Effects of insulin on muscle tissue
    • Wolfe R. Effects of insulin on muscle tissue. Curr Opin Clin Nutr Metab Care 3 (2000) 67-71
    • (2000) Curr Opin Clin Nutr Metab Care , vol.3 , pp. 67-71
    • Wolfe, R.1
  • 20
    • 0035038782 scopus 로고    scopus 로고
    • Mechanisms of nutritional and hormonal regulation of lipogenesis
    • Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2 (2001) 282-286
    • (2001) EMBO Rep , vol.2 , pp. 282-286
    • Kersten, S.1
  • 21
    • 0022005564 scopus 로고
    • Effect of insulin and glucose on feeding behavior
    • Rodin J., Wack J., Ferrannini E., and DeFronzo R. Effect of insulin and glucose on feeding behavior. Metabolism 34 (1985) 826-831
    • (1985) Metabolism , vol.34 , pp. 826-831
    • Rodin, J.1    Wack, J.2    Ferrannini, E.3    DeFronzo, R.4
  • 22
    • 4143116687 scopus 로고    scopus 로고
    • Weight gain during insulin therapy in patients with type 2 diabetes mellitus
    • Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Proct. 65 Suppl 1 (2004) S23-S27
    • (2004) Diabetes Res Clin Proct. , vol.65 , Issue.SUPPL. 1
    • Heller, S.1
  • 23
    • 0035516193 scopus 로고    scopus 로고
    • Changes in BMI and weight before and after the development of type 2 diabetes
    • Looker H., Knowler W., and Hanson R. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24 (2001) 1917-1922
    • (2001) Diabetes Care , vol.24 , pp. 1917-1922
    • Looker, H.1    Knowler, W.2    Hanson, R.3
  • 24
    • 0018341014 scopus 로고
    • Diabetes and cardiovascular risk factors: The Framingham study
    • Kannel W., and McGee D. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 59 (1979) 8-13
    • (1979) Circulation , vol.59 , pp. 8-13
    • Kannel, W.1    McGee, D.2
  • 25
    • 0027437262 scopus 로고
    • Medical hazards of obesity
    • Pi-Sunyer F. Medical hazards of obesity. Ann Intern Med. 119 (1993) 655-660
    • (1993) Ann Intern Med. , vol.119 , pp. 655-660
    • Pi-Sunyer, F.1
  • 26
    • 0025630035 scopus 로고
    • Insulin use in NIDDM
    • Genuth S. Insulin use in NIDDM. Diabetes Care 13 (1990) 1240-1264
    • (1990) Diabetes Care , vol.13 , pp. 1240-1264
    • Genuth, S.1
  • 27
    • 0019981441 scopus 로고
    • Insulin treatment reverses the insulin resistance of type II diabetes mellitus
    • Scarlett J., Gray R., Griffin J., et al. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5 (1982) 353-363
    • (1982) Diabetes Care , vol.5 , pp. 353-363
    • Scarlett, J.1    Gray, R.2    Griffin, J.3
  • 28
    • 0021223411 scopus 로고
    • Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal
    • Andrews W., Vasquez B., Nagulesparan M., et al. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 33 (1984) 634-642
    • (1984) Diabetes , vol.33 , pp. 634-642
    • Andrews, W.1    Vasquez, B.2    Nagulesparan, M.3
  • 29
    • 0021990787 scopus 로고
    • The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus
    • Garvey W., Olefsky J., Griffin J., et al. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34 (1985) 222-234
    • (1985) Diabetes , vol.34 , pp. 222-234
    • Garvey, W.1    Olefsky, J.2    Griffin, J.3
  • 30
    • 0036932148 scopus 로고    scopus 로고
    • A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia
    • Nambi V., Hoogwerf R., and Sprecher D. A truly deadly quartet: Obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. Cleve Clinic J Med 69 (2002) 985-989
    • (2002) Cleve Clinic J Med , vol.69 , pp. 985-989
    • Nambi, V.1    Hoogwerf, R.2    Sprecher, D.3
  • 31
    • 0024342099 scopus 로고
    • Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus
    • Groop L., Widen E., Franssila-Kallunki A., et al. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32 (1989) 599-605
    • (1989) Diabetologia , vol.32 , pp. 599-605
    • Groop, L.1    Widen, E.2    Franssila-Kallunki, A.3
  • 32
    • 0035668504 scopus 로고    scopus 로고
    • The effects of intensive glycaemic control on body composition in patients with type 2 diabetes
    • Bagg W., Plank L., Gamble G., et al. The effects of intensive glycaemic control on body composition in patients with type 2 diabetes. Diabetes Obes Metab 3 (2001) 410-416
    • (2001) Diabetes Obes Metab , vol.3 , pp. 410-416
    • Bagg, W.1    Plank, L.2    Gamble, G.3
  • 33
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 34
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Stratton I., Adler A., Neil H., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.1    Adler, A.2    Neil, H.3
  • 35
    • 0030974812 scopus 로고    scopus 로고
    • Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
    • for the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group
    • Malmberg K., for the DIGAMI (Diabetes Mellitus, and Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314 (1997) 1512-1515
    • (1997) BMJ , vol.314 , pp. 1512-1515
    • Malmberg, K.1
  • 36
    • 29144453326 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    • for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
    • Nathan D., Cleary P., Backlund J., et al., for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
    • (2005) N Engl J Med , vol.353 , pp. 2643-2653
    • Nathan, D.1    Cleary, P.2    Backlund, J.3
  • 37
    • 0030947226 scopus 로고    scopus 로고
    • Mealtime treatment with insulin ana log improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus
    • for the Multicenter Insulin Lispro Study Group
    • Anderson Jr. J., Brunelle R., Keohane P., et al., for the Multicenter Insulin Lispro Study Group. Mealtime treatment with insulin ana log improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 157 (1997) 1249-1255
    • (1997) Arch Intern Med , vol.157 , pp. 1249-1255
    • Anderson Jr., J.1    Brunelle, R.2    Keohane, P.3
  • 38
    • 0033867021 scopus 로고    scopus 로고
    • Less nocturnal hypoglycemia and better postdinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes
    • for the HOE 901/3002 Study Group
    • Yki-Jarvinen H., Dressler A., Ziemen M., and for the HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better postdinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23 (2000) 1130-1136
    • (2000) Diabetes Care , vol.23 , pp. 1130-1136
    • Yki-Jarvinen, H.1    Dressler, A.2    Ziemen, M.3
  • 39
    • 0034827469 scopus 로고    scopus 로고
    • Basal insulin therapy in type 2 diabetes: 28-Week comparison of insulin glargine (HOE 901) and NPH insulin
    • Rosenstock J., Schwartz S., Clark Jr. C., et al. Basal insulin therapy in type 2 diabetes: 28-Week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 24 (2001) 631-636
    • (2001) Diabetes Care , vol.24 , pp. 631-636
    • Rosenstock, J.1    Schwartz, S.2    Clark Jr., C.3
  • 40
    • 12744274870 scopus 로고    scopus 로고
    • Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
    • Hack T., Tiengo A., Draeger E., et al. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab 7 (2005) 56-64
    • (2005) Diabetes Obes Metab , vol.7 , pp. 56-64
    • Hack, T.1    Tiengo, A.2    Draeger, E.3
  • 41
    • 0343724362 scopus 로고    scopus 로고
    • Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus
    • A randomized, controlled trial
    • Yki-Jarvinen H., Ryysy L., Nikkila K., et al. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 130 (1999) 389-396
    • (1999) Ann Intern Med , vol.130 , pp. 389-396
    • Yki-Jarvinen, H.1    Ryysy, L.2    Nikkila, K.3
  • 42
    • 33646801658 scopus 로고    scopus 로고
    • Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus
    • Hoogwerf R. Exenatide and pramlintide: New glucose-lowering agents for treating diabetes mellitus. Cleve Clin J Med. 73 (2006) 477-484
    • (2006) Cleve Clin J Med. , vol.73 , pp. 477-484
    • Hoogwerf, R.1
  • 43
    • 0035512619 scopus 로고    scopus 로고
    • Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control
    • Gokcel A., Karakose H., Ertorer E., et al. Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. Diabetes Care 24 (2001) 1957-1960
    • (2001) Diabetes Care , vol.24 , pp. 1957-1960
    • Gokcel, A.1    Karakose, H.2    Ertorer, E.3
  • 44
    • 0036598137 scopus 로고    scopus 로고
    • Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial
    • Kelley D., Bray G., Pi-Sunyer F., et al. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial. Diabetes Care 25 (2002) 1033-1041
    • (2002) Diabetes Care , vol.25 , pp. 1033-1041
    • Kelley, D.1    Bray, G.2    Pi-Sunyer, F.3
  • 45
    • 8644223451 scopus 로고    scopus 로고
    • Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients
    • Derosa G., Cicero A., Murdolo G., et al. Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients. Diabetes Nutr Metob 17 (2004) 222-229
    • (2004) Diabetes Nutr Metob , vol.17 , pp. 222-229
    • Derosa, G.1    Cicero, A.2    Murdolo, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.